(R)-P7C3-Ome 1235481-43-2 P7C3 is a drug related to latrepirdine (dimebon), which has neuroprotective and proneurogenic effects

PFI-2 1627676-59-8 PFI-2 is a potent, selective, and cell-active lysine methyltransferase SETD7 inhibitor with Ki (app) and IC50 of 0.33 nM and 2 nM,

Atopaxar Hydrobromide 474550-69-1 Atopaxar Hydrobromide is a reversible protease activated receptor (PAR)-1 thrombin receptor antagonist that interferes with platelet signaling.

Atopaxar 751475-53-3 Atopaxar is a reversible protease activated receptor (PAR)-1 thrombin receptor antagonist that interferes with platelet signaling.

Cinaciguat 329773-35-5 Cinaciguat (BAY 58-2667) is the first of a new class of soluble guanylate cyclase (sGC) activators in clinical development for acute decompensated heart failure.

HA14-1 65673-63-4 HA14-1 is a non-peptidic ligand of a Bcl-2 surface pocket with IC50 of ~9 μM.

AVN944 297730-17-7 AVN-944(VX-944) is a selective, noncompetitive inhibitor of the enzyme directed against human IMPDH with Ki of 6-10 nM for IMPDH1/IMPDH2.

YL-109 36341-25-0 YL-109 is a novel anticancer agent which has ability to inhibit breast cancer cell growth and invasiveness in vitro and in vivo.